|
⚲
|
| Keyboard |
| Royalty Pharma Sub-Manager LLC
✚
|
|
|---|---|
| CRD # | 335070 |
| SEC # | 801-132133 |
| CIK # | 0002081668 |
| AUM | 19.64 B (2026-05-04) |
| Employees | 91 (53% Investors, 0% Brokers) |
| Phone | 212-883-0200 |
| Address | 110 East 59th Street New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Cytokinetics Inc | 64.6 | ||
| Bicara Therapeutics Inc | 46.7 | ||
| Biocryst Pharmaceuticals Inc | 36.6 | ||
| Biohaven Ltd | 24.8 | ||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | RPI International Partners 2019 LP | [2020-03-27] | 6.8 M | |
| Filed 2020-02-10 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| PE | RPI US Partners 2019 LP | [2020-03-27] | 1,439.4 M | |
| Filed 2020-02-10 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 7 | 19.6 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 7 | 19.6 |
| By Discretionary | ||
| Discretionary | 7 | 19.6 |
| Non-Discretionary | 0 | 0.0 |
| Total | 7 | 19.6 |
| By Non-United States Persons | ||
| Non-United States Persons | 19.6 | |
| United States Persons | 0.0 | |
| Total | 7 | 19.6 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Pablo Legorreta | Executive Officer | 12 | 3 | |
| Rpi GP 2019 LP | Executive Officer | 3 | 2 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002081668] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Comparable Firms | State | AUM |
|---|---|---|
|
Madison Dearborn Partners LLC
✚
|
IL | 20.74 B |
|
Harvest Partners LP
✚
|
NY | 20.25 B |
|
Deer Management Co LLC
✚
|
NY | 20.24 B |
|
Rokos Capital Management US LP
✚
|
NY | 20.20 B |
|
Audax Management Company LLC
✚
|
MA | 20.12 B |
|
KPS Capital Partners LP
✚
|
NY | 19.08 B |
|
Great Hill Partners LP
✚
|
MA | 18.99 B |
|
Alpine Management Services III LLC
✚
|
CA | 18.91 B |
|
American Securities LLC
✚
|
NY | 18.91 B |
|
Monroe Capital Management Advisors LLC
✚
|
IL | 18.56 B |